Efficacy of Dulaglutide Expanded Doses by Baseline A1C Categories: Post Hoc Analysis of AWARD-11

por Frias, Juan Pablo, Bonora, Enzo, Cox, David A, Kwan, Anita, Raha, Sohini, Bethel, Angelyn, Malik, Raleigh
Publicado 2021

HbA(1c) Reduction in Dulaglutide-Treated Patients Irrespective of Duration of Diabetes, Microvascular Disease, and BMI: A Post Hoc Analysis From the REWIND Trial

por Kwan, Anita Y.M., Gerstein, Hertzel C., Basile, Jan, Xavier, Denis, Maldonado, Juan M., Raha, Sohini, Konig, Manige
Publicado 2022

Glycaemic efficacy of an expanded dose range of dulaglutide according to baseline glycated haemoglobin (HbA1c) subgroup: Post hoc analysis of AWARD‐11

por Frias, Juan P., Bonora, Enzo, Cox, David A., Bethel, M. Angelyn, Kwan, Anita Y.M., Raha, Sohini, Malik, Raleigh E.
Publicado 2021

Gastrointestinal Tolerability of Once-Weekly Dulaglutide 3.0 mg and 4.5 mg: A Post Hoc Analysis of the Incidence and Prevalence of Nausea, Vomiting, and Diarrhea in AWARD-11

por Van, Joanna, Frias, Juan P., Bonora, Enzo, Raha, Sohini, Meyer, Jarrett, Jung, Heike, Cox, David, Konig, Manige, Peleshok, Jennifer, Bethel, M. Angelyn
Publicado 2021

General versus central adiposity as risk factors for cardiovascular-related outcomes in a high-risk population with type 2 diabetes: a post hoc analysis of the REWIND trial

por Franek, Edward, Pais, Prem, Basile, Jan, Nicolay, Claudia, Raha, Sohini, Hickey, Ana, Ahmad, Nadia N., Konig, Manige, Kan, Hong, Gerstein, Hertzel C.
Publicado 2023

Efficacy and safety of dulaglutide 3.0 and 4.5 mg in patients aged younger than 65 and 65 years or older: Post hoc analysis of the AWARD‐11 trial

por Frias, Juan P., Bonora, Enzo, Nevárez Ruiz, Luis, Hsia, Stanley H., Jung, Heike, Raha, Sohini, Cox, David A., Bethel, M. Angelyn, Konig, Manige
Publicado 2021

Exploring potential mediators of the cardiovascular benefit of dulaglutide in type 2 diabetes patients in REWIND

por Konig, Manige, Riddle, Matthew C., Colhoun, Helen M., Branch, Kelley R., Atisso, Charles M., Lakshmanan, Mark C., Mody, Reema, Raha, Sohini, Gerstein, Hertzel C.
Publicado 2021

Efficacy and Safety of Dulaglutide in Older Patients: A post hoc Analysis of the REWIND trial

por Riddle, Matthew C, Gerstein, Hertzel C, Xavier, Denis, Cushman, William C, Leiter, Lawrence A, Raubenheimer, Peter J, Atisso, Charles M, Raha, Sohini, Varnado, Oralee J, Konig, Manige, Lakshmanan, Mark, Franek, Edward
Publicado 2021